A rare Mendelian syndrome-pseudohypoaldosteronism type II (PHA-II)-features hypertension, hyperkalemia, and metabolic acidosis. Genetic linkage studies and exome sequencing have identified four genes-with no lysine kinase 1 (wnk1), wnk4, Kelch-like 3 (KLHL3), and Cullin 3 (Cul3)-mutations of which all caused PHA-II phenotypes. The previous hypothesis was that the KLHL3-Cul3 ubiquitin complex acted on the wnk4-wnk1 kinase complex to regulate Na + /Cl − cotransporter (NCC) mediated salt reabsorption in the distal tubules of the kidney. Here, we report the identification of claudin-8 as a previously unidentified physiologic target for KLHL3 and provide an alternative explanation for the collecting duct's role in PHA-II. Using a tissue-specific KO approach, we have found that deletion of claudin-8 in the collecting duct of mouse kidney caused hypotension, hypokalemia, and metabolic alkalosis, an exact mirror image of PHA-II. Mechanistically, the phenotypes in claudin-8 KO animals were caused by disruption of the claudin-8 interaction with claudin-4, the paracellular chloride channel, and delocalization of claudin-4 from the tight junction. In mouse collecting duct cells, knockdown of KLHL3 profoundly increased the paracellular chloride permeability. Mechanistically, KLHL3 was directly bound to claudin-8, and this binding led to the ubiquitination and degradation of claudin-8. The dominant PHA-II mutation in KLHL3 impaired claudin-8 binding, ubiquitination, and degradation. These findings have attested to the concept that the paracellular pathway is physiologically regulated through the ubiquitination pathway, and its deregulation may lead to diseases of electrolyte and blood pressure imbalances.ordon's syndrome, also known as pseudohypoaldosteronism II (PHA-II) or familial hyperkalemic hypertension, features several metabolic derangements, including hypertension, hyperkalemia, and hyperchloremic metabolic acidosis (1). Mutations in four genes have been found to cause Gordon's syndrome. Two encode the serine-threonine kinases with no lysine kinases (WNKs) (2). The other two encode proteins important in the cullin-really interesting new gene E3 ubiquitin ligase (CRL) complexKelch-like 3 (KLHL3) and Cullin 3 (CUL3) (3, 4). Diseasecausing mutations in WNKs are dominant and confer gain of function to augment NaCl reabsorption in the distal convoluted tubule (DCT) by a signaling cascade of SPAK/OSR1 to NCC (5, 6). Mutations in KLHL3 are either recessive or dominant. Recessive mutations include premature termination, frameshift, and splicing alternatives, consistent with loss of function, whereas dominant mutations cluster in the β-propeller domain important in target recognition (3, 4). CUL3 mutations are all dominant and de novo and result in the skipping of exon 9 and in-frame deletion of a 57-aa segment important in maintaining the CRL architecture (3). KLHL3 was found to interact with WNK4 and regulate its ubiquitination and degradation (7,8). Presumably, loss of KLHL3 function may lead to increases in WNK4 protein le...